Estudo randomizado | Em pacientes submetidos a cirurgia cardíaca, alta dose de selênio intravenoso não reduziu a morbidade ou a mortalidade
16 Jan, 2023 | 10:43h
Comentário no Twitter
In this study, high-dose sodium selenite was not effective in reducing the development of organ dysfunction and death in high-risk cardiac surgery patients. @CStoppe @CriticalCa https://t.co/H3HR1u1HhU
— JAMA Surgery (@JAMASurgery) January 12, 2023